Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00183898
Status:
UNKNOWN
Last Update Posted:
2019-05-16
First Post:
2005-09-09
Brief Title:
Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer
Sponsor:
University of Southern California
Organization:
University of Southern California
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Esophageal Cancer |
| Gastric Cancer |
Keywords:
| Name | View |
|---|---|
| Gastroesophageal Junction Cancer | View |